Additionally, glutamate modulators, like ceftriaxone, can alleviate depression symptoms by inhibiting neuroinflammation via the GLT-1/TrkB signaling pathway (Gao et al., 2024). The gene discussed is SLC1A2; the disease is major depressive disorder.